NAXARMI
DEAD

Serial Number

88752701

Owner

PFIZER INC.

Attorney

Richard A. Friedman

Filing Date

Jan 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NAXARMI Trademark

Serial Number: 88752701

NAXARMI is a trademark filed by PFIZER INC. on January 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

PFIZER INC. (4,631 trademarks)

NEW YORK, NY 10017

Entity Type: 03

Trademark Details

Filing Date

January 9, 2020

Registration Date

Not Registered

Published for Opposition

October 13, 2020

Goods & Services

Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals, namely, narcotic antagonists; Injectable pharmaceuticals, namely, opioid antagonists

Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Nov 21, 2022 MAB5
ABANDONMENT - AFTER PUBLICATION
Nov 21, 2022 ABN5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2022 EXRA
TEAS EXPRESS ABANDONMENT RECEIVED
Nov 18, 2022 EXAR
SOU EXTENSION 4 GRANTED
Nov 17, 2022 EX4G
SOU EXTENSION 4 FILED
Nov 17, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 17, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2022 EXRA
SOU EXTENSION 3 GRANTED
May 10, 2022 EX3G
SOU EXTENSION 3 FILED
May 10, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
May 10, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 1, 2021 EXRA
SOU EXTENSION 2 GRANTED
Nov 29, 2021 EX2G
SOU EXTENSION 2 FILED
Nov 29, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 29, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 22, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 22, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 22, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 13, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 13, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 8, 2020 CRFA
ASSIGNED TO LIE
Sep 3, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 14, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2020 NWOS
NEW APPLICATION ENTERED
Jan 13, 2020 NWAP